
Insomnia
Overview
Insomnia is persistent difficulty in falling asleep, staying asleep, or waking too early, despite having the desire and opportunity for sleep. The loss of continuous deep sleep keeps stress‑hormone levels elevated, impairs tissue repair, and prevents the brain’s nightly waste‑clearance cycle.
Health Consequences
A 2024 meta‑analysis confirmed that chronic insomnia is an independent risk factor for atrial fibrillation, myocardial infarction, and hypertension. Fragmented sleep also disrupts leptin/ghrelin balance, promoting weight gain and insulin resistance.
Rebis Treatment Approach
The strategy for treating insomnia at Rebis starts with the recognition that “insomnia” is a problem to be solved, not merely a “symptom” or diagnosis to be treated. At Rebis, we recognize that each person experiences the sleep-wake experience differently, and that as a rule, there are typically multiple factors that contribute to an individual’s experience of “I can’t sleep”!
What you’ll experience in the Rebis ecosystem:
Collaborative problem-solving of each patient’s individual narrative using the Five
Cognitive Behavioral Therapy for Insomnia (CBT‑I) strategies:
Proactive Wind-Down Time
Sleep Restriction Therapy/Chronotherapy
Stimulus Control Therapy
Timed light therapy and circadian re‑anchoring
Cognitive restructuring and guided distraction techniques
Option for Integrative Medicine pathway to address root cause pathology
Expanded lab work to assess nutrient, hormone, and inflammation status
Integrated stress‑modulation strategies (breathwork, craniosacral therapy)
Pharmacologic management strategies, if appropriate
Benefits of Treatment
The restorative quality of sleep is undeniable! Benefits of improved sleep can include: improved mental health, lower blood pressure, better metabolic control, healthier labs, and brighter days!
Connection to Other Health Domains
System | Untreated Impact | Key Evidence |
---|---|---|
Cardiovascular & Metabolic |
≈50% higher myocardial-infarction risk; elevated blood pressure | J Clin Sleep Med 2024 meta-analysis |
Hormone Imbalances | Evening cortisol spikes; altered leptin/ghrelin drive hunger | Physiol Behav 2022 study |
Immune / Chronic Pain | ↑ inflammatory cytokines; lowered pain threshold | Multiple cohort studies |
Gastrointestinal | 65% higher risk of developing IBS alongside shift-work insomnia | Gut 2025 cohort |
-
Associations between insomnia and cardiovascular diseases – https://jcsm.aasm.org/doi/10.5664/jcsm.11326
Effects of acute sleep loss on leptin and ghrelin – https://pubmed.ncbi.nlm.nih.gov/36404495/
Rotating shift work, insomnia and IBS risk – https://pubmed.ncbi.nlm.nih.gov/40206171/